PUBLISHER: Market Research Future | PRODUCT CODE: 1457897
PUBLISHER: Market Research Future | PRODUCT CODE: 1457897
Europe Pen Needles Market Research Report Forecast to 2032
Europe Pen Needles Market is anticipated to register a significant CAGR of 8.61% by 2032. A pen needle is a medical device used in conjunction with injection pens to administer medications by subcutaneous injection. Injection pens are commonly used for the self-administration of insulin by individuals with diabetes, as well as for other injectable medications. Pen needles are attached to the injection pen and are designed to deliver the medication beneath the skin.
The Europe pen needle market is predicted to expand due to increasing prevalence of diabetes, obesity, and other chronic diseases rising awareness of self-administration, and patient preference for pen devices, However, regulatory challenges is limiting market expansion. technological innovation and patient-centric solutions on the other hand, boosts the market's attractiveness. The Europe pen needle market has experienced notable expansion, driven significantly by the rising awareness of self-administration of injectable medications.
Based on brand, the Europe pen needles market has been segmented into standard pen needle and safety pen needle. The standard pen needle segment held the largest market in 2022 and is the fastest growing segment during the forecast period.
Based on needle length, the Europe pen needle market has been segmented into 4mm, 5mm, 6mm, 8mm, 10mm and 12.7mm. The 4mm segment held the largest market in 2022 and is the fastest growing segment during the forecast period.
Based on application, the Europe pen needle market has been segmented into insulin therapy, GLP-1 therapy, growth hormone therapy, osteoporosis, and others. The insulin therapy segment held the largest market in 2022 and is the fastest growing segment during the forecast period.
Based on distribution channel, the Europe pen needle market has been segmented into direct sales and distributors. The distributors segment held the largest market in 2022 and is the fastest growing segment during the forecast period.
Based on end user, the Europe pen needle market has been segmented into hospitals & clinics, homecare settings, and others. The homecare settings segment held the largest market in 2022 and is the fastest growing segment during the forecast period.
The Europe pen needles market is segmented into the France and Rest of Europe. The Rest of Europe held the largest market share of 82.99% based on region and is anticipated to dominate the overall needle pen market during the forecast period.
The key players operating in the market are Novo Nordisk A/S, Terumo Corporation, Embecta Corp., Ypsomed Holdings AG, MTD Medical Technology and Devices, Novo Nordisk A/S, Terumo Corporation, Embecta Corp., Ypsomed Holdings AG, and MTD Medical Technology and Devices.